Taxol and Implant site effusion - a phase IV clinical study of FDA data


Implant site effusion is reported only by a few people who take Taxol.

The phase IV clinical study analyzes which people take Taxol and have Implant site effusion. It is created by eHealthMe based on reports of 31,877 people who have side effects while taking Taxol from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 05, 2022

31,877 people reported to have side effects when taking Taxol.
Among them, 2 people (0.01%) have Implant site effusion.

What is Taxol?

Taxol has active ingredients of paclitaxel. It is often used in breast cancer. eHealthMe is studying from 32,112 Taxol users for its effectiveness, alternative drugs and more.

What is Implant site effusion?

Implant site effusion is found to be associated with 182 drugs and 107 conditions by eHealthMe.

Number of Taxol and Implant site effusion reports submitted per year:

Could Taxol cause Implant site effusion?

Gender of people who have Implant site effusion when taking Taxol *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Implant site effusion when taking Taxol *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 100 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Taxol *:

  1. Carboplatin: 2 people, 100.00%
  2. Cephalexin: 1 person, 50.00%
  3. Fentanyl: 1 person, 50.00%
  4. Erlotinib Hydrochloride: 1 person, 50.00%
  5. Doxycycline: 1 person, 50.00%
  6. Dilaudid: 1 person, 50.00%
  7. Dexamethasone: 1 person, 50.00%
  8. Cymbalta: 1 person, 50.00%
  9. Compazine: 1 person, 50.00%
  10. Chlorhexidine Gluconate: 1 person, 50.00%

Common side effects people have besides Implant site effusion *:

  1. Haematochezia (passage of stools containing blood): 2 people, 100.00%
  2. White Blood Cell Count Decreased: 1 person, 50.00%
  3. Compression Fracture (fracture due to pressure caused by injury): 1 person, 50.00%
  4. Haemoglobin Decreased: 1 person, 50.00%
  5. Haematuria (presence of blood in urine): 1 person, 50.00%
  6. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 1 person, 50.00%
  7. Fever: 1 person, 50.00%
  8. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 50.00%
  9. Constipation: 1 person, 50.00%
  10. Colon Cancer Metastatic (cancer of colon spreads to other part of body): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Taxol and have Implant site effusion?

Check whether Implant site effusion is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Implant site effusion and when was it recovered:

Expand to all the drugs that have ingredients of paclitaxel:

Alternative drugs to, pros and cons of Taxol:

Common Taxol side effects:

Browse all side effects of Taxol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Implant site effusion treatments and more:

COVID vaccines that are related to Implant site effusion:

Common drugs associated with Implant site effusion:

All the drugs that are associated with Implant site effusion:

Common conditions associated with Implant site effusion:

All the conditions that are associated with Implant site effusion:

How the study uses the data?

The study uses data from the FDA. It is based on paclitaxel (the active ingredients of Taxol) and Taxol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: